Publication Date:
1993-04-23
Description:
Transforming growth factor-beta (TGF-beta) is a naturally occurring growth inhibitory polypeptide that arrests the cell cycle in middle to late G1 phase. Cells treated with TGF-beta contained normal amounts of cyclin E and cyclin-dependent protein kinase 2 (Cdk2) but failed to stably assemble cyclin E-Cdk2 complexes or accumulate cyclin E-associated kinase activity. Moreover, G1 phase extracts from TGF-beta-treated cells did not support activation of endogenous cyclin-dependent protein kinases by exogenous cyclins. These effects of TGF-beta, which correlated with the inhibition of retinoblastoma protein phosphorylation, suggest that mammalian G1 cyclin-dependent kinases, like their counterparts in yeast, are targets for negative regulators of the cell cycle.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Koff, A -- Ohtsuki, M -- Polyak, K -- Roberts, J M -- Massague, J -- New York, N.Y. -- Science. 1993 Apr 23;260(5107):536-9.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8475385" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
*CDC2-CDC28 Kinases
;
Cell Extracts
;
Cell Line
;
Cyclin-Dependent Kinase 2
;
*Cyclin-Dependent Kinases
;
Cyclins/*metabolism/pharmacology
;
Enzyme Activation/drug effects
;
*G1 Phase
;
Mink
;
Phosphorylation
;
Protein Kinases/*metabolism
;
*Protein-Serine-Threonine Kinases
;
Retinoblastoma Protein/metabolism
;
Transforming Growth Factor beta/*pharmacology
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink